title: Sirolimus plus calcineurin inhibitors and methotrexate: is more necessarily better?
authors: Stem Cell Transplantation Program, Department of Medicine, University Hospitals Seidman Cancer Center, Case Western Reserve University , Cleveland, OH , USA.
authors: Basem M
authors: BM
authors: William
authors: Marcos
authors: M
authors: de Lima
mesh_terms: D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*; D019172:Transplantation Conditioning / Q000379:methods*; D061349:Unrelated Donors
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus; D016559:Tacrolimus; D008727:Methotrexate